Article
Investigation of RBM10 mutation and its associations with clinical and molecular characteristics in EGFR-mutant and EGFR-wildtype lung adenocarcinoma
31 May 2024
Abstract excerpt
Background RBM10 is commonly mutated in lung adenocarcinoma (LUAD). However, its role in the pathogenesis of LUAD remains undefined. EGFR -mutant LUAD represents a distinct subset of non-small cell lung cancer (NSCLC). The function of RBM10 in tumor pathogenesis is supposed to differ between EGFR -mutant and EGFR -wt LUAD. This study aimed to interrogate the prevalence of RBM10 mutation in a large cohort of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
